Dear %%first_name%%,
When the Oracle of Omaha, Warren Buffett, goes after a stock he looks at a number of markers. Over subsequent months I intend to take a number of companies and assess them according to these markers to try and answer this question: Would Warren Buffett buy this stock? A former market darling caught out by the Brexit drama is the first company to sit my test.
It’s important your SMSF is compliant and one area attracting attention lately is a fund’s investment strategy. What’s your investment objective and how will it support your retirement plans? In order to check yours, Paul Rickard gives his 4 steps to pitch yours against to see if your SMSF strategy stacks up.
As James Dunn notes in his article today, biotech is an interesting and potentially lucrative hunting ground for investors but comes with big caveats – the news flow in biotech stocks can giveth and taketh away, in nerve-racking falls and heart-pumping rises. James offers 4 candidates, where a small proportion of funds could be put aside for an informed (hopefully!) punt that could pay off big-time – but they’re all tagged “Beware”.
Today in our “Hot” Stock, CMC Markets’ Chief Market Strategist, Michael McCarthy explains why he likes A2 Milk (A2M) but doesn’t like Collin’s Food (CKF).
And in Buy, Sell, Hold — What the Brokers Say, FNArena registered 5 upgrades and 7 downgrades for the week ending Friday 20 September 2019 from the 7 stockbrokers monitored daily.
Finally as a bonus today, Julia Lee, Portfolio Manager, Burman Invest, explains why she likes Smart Group (SIQ) but doesn’t like GPT.
Tickets for our next conference, the Switzer Income Conference in Sydney, Melbourne and Brisbane, are now available. Click on the event you would like to attend below:
And pick up a copy of my book Join the Rich Club from the Switzer Store today.
Enjoy the read and your week!
Sincerely,
Peter Switzer